Enhanced TDS
Identification & Functionality
- Ingredient Name
- Food Ingredients Functions
- Pharma & Nutraceuticals Functions
- Technologies
- Product Families
Features & Benefits
- Benefit Claims (Health)
- Product Background
- Diabetes, a chronic disease with mild early symptoms, often goes undetected for years.
- Global diabetes prevalence is steadily increasing, projected to reach 10.9% by 2045.
- Type 2 diabetes, accounting for 90% of cases, is influenced by acquired dietary habits, age, and obesity.
- In Taiwan, 11.1% of adults have diabetes, with potential complications like stroke, heart disease, and kidney disease posing serious health risks.
- The gut microbiota plays a vital role in metabolism, and imbalances have been linked to diabetes and inflammatory responses.
- Product Benefits
- Research center has developed the MB0201 strain combination, comprising Lactobacillus reuteri GL-104 and Lactobacillus salivarius AP-32, specifically for Type 2 diabetes.
- These strains stabilize blood sugar levels, improve hyperlipidemia symptoms, and possess anti-inflammatory properties, promoting pancreatic β cell health and achieving blood sugar stability.
Applications & Uses
Properties
- Typical Properties
Value Units Test Method / Conditions Viable Microorganisms Count 1000 billion CFU/g
Regulatory & Compliance
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.